This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here's Why You Should Add Apogee Stock to Your Portfolio Now
by Zacks Equity Research
Apogee Enterprises (APOG) appears a prudent investment option backed by its focus on improving efficiency and productivity of operations and efforts to increase market share through acquisitions.
Here's Why You Should Hold On to Dover (DOV) Stock for Now
by Zacks Equity Research
Dover (DOV) is worth retaining in the portfolio at the moment, backed by robust backlog and cost-reduction initiatives.
Flowserve (FLS) Displays Strong Prospects Despite Risks
by Zacks Equity Research
Flowserve (FLS) benefits from its strong backlog level, investments in enhancing organic growth and robust liquidity position. However, weakness in oil and gas end markets remains concerning.
4 Industrial Stocks to Buy as U.S. May Retail Sales Instill Hope
by Namrata Chatterjee
As the manufacturing sector is gradually showing signs of revival, we suggest investors to add these four industrial stocks in their portfolio with positive growth projections.
Forget Caterpillar, Buy These 4 Industrial Stocks Instead
by Madhurima Das
With Caterpillar's (CAT) retail sales growth in the red for six consecutive months, we suggest investors to add these four industrial stocks with positive growth projections to their portfolio.
iRobot (IRBT) Hikes Q2 Sales and Operating View, Stock Rises
by Zacks Equity Research
iRobot (IRBT) hikes sales projections for Q2, primarily driven by healthy orders for Roomba and Braava products. Also, it reiterates that the second half of 2020 will be better than the first half.
Caterpillar (CAT) May Retail Sales Fare the Worst Since 2016
by Zacks Equity Research
Caterpillar's (CAT) global retail sales have been in the negative territory for six straight months amid a weak manufacturing backdrop, coronavirus-induced crisis and oil price rout.
Here's Why You Should Add Astec (ASTE) to Your Portfolio Now
by Zacks Equity Research
Astec's (ASTE) expected savings from restructuring activities, focus on innovation and a strong balance sheet make it a compelling investment option.
Xylem (XYL) Declines 19% YTD: What's Affecting the Stock?
by Zacks Equity Research
Xylem (XYL), with shares down 19% so far in 2020, faces risks from difficult end-market conditions due to the pandemic, forex woes and cost inflation. Q2 organic sales are likely to fall 20-30% y/y.
Tetra Tech (TTEK) Announces Its Financial Outlook for FY20
by Zacks Equity Research
Tetra Tech (TTEK) provides its outlook for the third quarter and fiscal 2020.
Here's Why You Should Hold On to Greif (GEF) Stock for Now
by Zacks Equity Research
Greif (GEF) is worth retaining in the portfolio at the moment backed by its strong earnings growth, the Caraustar acquisition, and focus on operational execution and cost-reduction activities.
Graco's HydroShield Waterborne System to Aid in Spraying Tasks
by Zacks Equity Research
Graco's (GGG) HydroShield Waterborne System is developed to help manufacturers in simplifying waterborne material-spraying tasks.
Here's Why You Should Hold On to Timken (TKR) Stock for Now
by Zacks Equity Research
Timken (TKR) is worth retaining in the portfolio at the moment on its efforts to reduce costs, acquisitions and strengthen product offerings.
O-I Glass' April, May Shipment Down 18% on Coronavirus Crisis
by Zacks Equity Research
O-I Glass' (OI) quarter-to-date global shipment volumes decline on the coronavirus crisis, while sales volume revives on gradual market reopening.
Berry Global (BERY) Gains From RPC Buyout Amid Cost Woes
by Zacks Equity Research
Berry Global (BERY) benefits from its strong portfolio of products, strength across the healthcare, hygiene and grocery end-markets, and the buyout of RPC. However, rising costs remain concerning.
Here's Why You Should Avoid Betting on Fortune Brands (FBHS)
by Zacks Equity Research
Fortune Brands (FBHS) has been suffering from a soft-demand environment amid the coronavirus outbreak, rising operating costs and several other issues.
Greif (GEF) Tops Q2 Earnings Estimates, Scraps FY20 Guidance
by Zacks Equity Research
Greif's (GEF) Q2 top line shrinks on dismal volume of primary products sold, product mix and unfavorable currency-translation impact.
Ball Corp (BLL) Shares Up 15% YTD: What's Driving the Rally?
by Zacks Equity Research
Ball Corp's (BLL) growth likely to be aided by increasing beverage-can demand through investments in capacity and products.
Stanley Black (SWK) Hikes Q2 Organic Sales View, Stock Rises
by Zacks Equity Research
Stanley Black (SWK) hikes organic sales projections for the second quarter of 2020, driven by strengthening of retail channels in the United States. Cost-reduction actions are expected to be beneficial.
Enersys (ENS) Suffers From Soft End Markets Amid Pandemic
by Zacks Equity Research
Enersys (ENS) is experiencing difficult end-market conditions on account of the coronavirus outbreak-led market downturn. Also, its high debt level is concerning.
Carlisle (CSL) Declines 19.6% YTD: What's Hurting the Stock?
by Zacks Equity Research
Carlisle (CSL) has been suffering from weak end markets on account of the coronavirus outbreak-led uncertainties, high debt level and other issues.
Astec (ASTE) to Gain From Restructuring Efforts & Innovation
by Zacks Equity Research
Astec (ASTE) remains well poised for the long term aided by global population growth, increased urbanization and the need to repair the ageing infrastructure.
Grainger (GWW) to Divest European MRO Product Supplier Fabory
by Zacks Equity Research
Grainger (GWW) continues to offer broad-line MRO products to Western Europe customers through Cromwell and Zoro.
Silgan Buys Albea's Dispensing Unit, Expands Closures Business
by Zacks Equity Research
Silgan's (SLGN) recent buyout is a strategic fit for the closures business and is likely to strengthen its position in the dispensing markets.
Nordson (NDSN) Buys Fluortek, Strengthens Product Offerings
by Zacks Equity Research
Nordson's (NDSN) buyout of Fluortek will likely enable it to strengthen its product offerings in the medical device market.